Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Gastritis III: Clinical Manifestations and Management01:23

Gastritis III: Clinical Manifestations and Management

The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Gastritis-I: Introduction and Types01:27

Gastritis-I: Introduction and Types

Gastritis, defined by the inflammation or irritation of the stomach lining or gastric mucosa, manifests in several distinct forms: acute, chronic, reactive, and a specific subtype known as autoimmune metaplastic atrophic gastritis.
Acute gastritis presents as a sudden inflammation triggered by various stressors to the stomach lining, such as exposure to corrosive agents, local irritants like aspirin and other NSAIDs, alcohol consumption, radiation therapy, physical trauma, severe burns, sepsis,...
Serum Laboratory Studies, Stool Test, Breath Test01:30

Serum Laboratory Studies, Stool Test, Breath Test

Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical Characteristics and Outcomes of Acute Intermittent Porphyria: Insights From the European Porphyria Registry.

Liver international : official journal of the International Association for the Study of the Liver·2026
Same author

Real-world evidence supports the safety and efficacy profile of luspatercept in clinically complex and heavily iron-overloaded patients.

British journal of haematology·2026
Same author

Narratives unveil knowledge and awareness-related issue, reinforcing patients' self-identity in sickle cell disease.

Orphanet journal of rare diseases·2026
Same author

New cases of δ-aminolevulinic acid dehydratase deficiency: Functional insights into gene variants using an innovative mouse liver model.

Journal of internal medicine·2025
Same author

Pregnancy and childbirth in women with thalassemia: past and present.

Haematologica·2025
Same author

The Relationship Between Non-Transferrin-Bound Iron (NTBI), Labile Plasma Iron (LPI), and Iron Toxicity.

International journal of molecular sciences·2025

Related Experiment Videos

Gaucher disease: a diagnostic challenge for internists.

Elena Cassinerio1, Giovanna Graziadei1, Erika Poggiali2

  • 1Rare Diseases Center, Department of Medicine and Medical Specialities, "Ca' Granda" Foundation IRCCS Ospedale Maggiore Policlinico, University of Milan, Italy.

European Journal of Internal Medicine
|October 5, 2013
PubMed
Summary

Gaucher disease (GD) is a common inherited lysosomal storage disorder affecting multiple organs. Early diagnosis through enzyme activity and molecular analysis is crucial for proper treatment and avoiding complications.

Keywords:
ChitotriosidaseGaucher diseaseGlucocerebrosideLysosomial disordersRare diseases

Related Experiment Videos

Area of Science:

  • Genetics and Molecular Biology
  • Metabolic Disorders
  • Hematology

Background:

  • Gaucher disease (GD) is the most prevalent inherited lysosomal storage disorder.
  • It results from an autosomal recessive defect in the glucocerebrosidase gene, leading to glucosylceramide accumulation.
  • GD is clinically heterogeneous, classified into neuronopathic (types 2 & 3) and non-neuronopathic (type 1) forms.

Purpose of the Study:

  • To highlight the diagnostic challenges of Gaucher disease for internists.
  • To emphasize the importance of early and accurate diagnosis for effective patient management.
  • To outline the diagnostic process and necessary assessments for Gaucher disease.

Main Methods:

  • Diagnosis is confirmed by measuring betaglucocerebrosidase activity in peripheral leukocytes.
  • Molecular analysis of the glucocerebrosidase gene is essential for confirmation.
  • Comprehensive multisystemic assessment and regular follow-up are required for staging disease burden.

Main Results:

  • Clinical presentation and organ involvement in GD are highly variable.
  • Common presenting features include splenomegaly and thrombocytopenia.
  • Skeletal complications, hepatomegaly, and neurological manifestations (in neuronopathic forms) are significant clinical concerns.

Conclusions:

  • Early and accurate diagnosis of Gaucher disease is critical for timely and appropriate treatment.
  • Effective management involves thorough initial assessment and consistent follow-up.
  • Prompt diagnosis helps prevent disease complications and improve patient outcomes.